C. Benedict and F. G. De-felice, A key role of insulin receptors in memory, Diabetes, vol.64, pp.3653-3655, 2015.

C. Bing, H. M. Frankish, L. Pickavance, Q. Wang, D. F. Hopkins et al., Hyperphagia in cold-exposed rats is accompanied by decreased plasma leptin but unchanged hypothalamic NPY, Am. J. Phys, vol.274, issue.1, pp.62-68, 1998.

S. R. Bloom, A. V. Edwards, R. N. Hardy, K. W. Malinowska, and M. Silver, Endocrine responses to insulin hypoglycaemia in the young calf, J. Physiol, vol.244, issue.3, pp.783-803, 1975.

T. R. Bomfim, L. Forny-germano, L. B. Sathler, J. Brito-moreira, J. C. Houzel et al., An antidiabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated A? oligomers, J. Clin. Invest, vol.122, issue.4, pp.1339-1353, 2012.

H. Braak, D. R. Thal, E. Ghebremedhin, and K. Del-tredici, J Neuropathol Exp Neurol, vol.70, issue.11, pp.960-969, 2011.

L. M. Brown, D. J. Clegg, S. C. Benoit, and S. C. Woods, Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice, Physiol. Behav, vol.89, pp.687-691, 2006.

J. C. Brüning, D. Gautam, D. J. Burks, J. Gillette, M. Schubert et al., Role of brain insulin receptor in control of body weight and reproduction, Science, vol.289, pp.2122-2125, 2000.

S. Burnouf, A. Martire, M. Derisbourg, C. Laurent, K. Belarbi et al., NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model, Aging Cell, vol.12, issue.1, pp.11-23, 2013.

P. Caroni, Overexpression of growth-associated proteins in the neurons of adult transgenic mice, J. Neurosci. Methods, vol.71, issue.1, pp.3-9, 1997.

J. R. Clarke, N. M. Silva, C. P. Figueiredo, R. L. Frozza, J. H. Ledo et al., Alzheimer-associated A? oligomers impact the central nervous system to induce peripheral metabolic deregulation, EMBO Mol. Med, vol.7, issue.2, pp.190-210, 2015.

F. G. De-felice, Alzheimer's disease and insulin resistance: translating basic science into clinical applications, J. Clin. Invest, vol.123, issue.2, pp.531-539, 2013.

S. M. De-la-monte, Type 3 diabetes is sporadic Alzheimer's disease: mini-review, Eur. Neuropsychopharmacol, vol.24, issue.12, pp.1954-1960, 2014.

C. Duyckaerts, M. Bennecib, Y. Grignon, T. Uchihara, Y. He et al., Modeling the relation between neurofibrillary tangles and intellectual status, Neurobiol. Aging, vol.18, issue.3, pp.267-273, 1997.

F. Gachon, U. Loizides-mangold, V. Petrenko, and C. Dibner, Glucose homeostasis: regulation by peripheral circadian clocks in rodents and humans, Endocrinology, vol.158, issue.5, pp.1074-1084, 2017.

M. Gratuze, A. Joly-amado, D. Vieau, L. Buée, and D. Blum, Mutual relationship between Tau and central insulin signalling: consequences for AD and tauopathies, Neuroendocrinology, vol.107, issue.2, pp.181-195, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01833302

C. A. Grillo, K. L. Tamashiro, G. G. Piroli, S. Melhorn, J. T. Gass et al., Lentivirusmediated downregulation of hypothalamic insulin receptor expression, Physiol. Behav, vol.92, issue.4, pp.691-701, 2007.

C. A. Grillo, G. G. Piroli, R. C. Lawrence, S. A. Wrighten, A. J. Green et al., Hippocampal insulin resistance impairs spatial learning and synaptic plasticity, Diabetes, vol.64, issue.11, pp.3927-3936, 2015.

E. Grober, D. Dickson, M. J. Sliwinski, H. Buschke, M. Katz et al., Memory and mental status correlates of modified Braak staging, Neurobiol. Aging, vol.20, issue.6, pp.573-579, 1999.

M. Ishii, G. Wang, G. Racchumi, J. P. Dyke, and C. Iadecola, Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons, J. Neurosci, vol.34, issue.27, pp.9096-9106, 2014.

A. Joly-amado, K. S. Serraneau, M. Brownlow, C. Marín-de-evsikova, J. R. Speakman et al., Metabolic changes over the course of aging in a mouse model of tau deposition, Neurobiol. Aging, vol.44, pp.62-73, 2016.

M. Jucker and L. C. Walker, Self-propagation of pathogenic protein aggregates in neurodegenerative diseases, Nature, vol.501, issue.7465, pp.45-51, 2013.

D. Kapogiannis, A. Boxer, J. B. Schwartz, E. L. Abner, A. Biragyn et al., Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease, FASEB J, vol.29, issue.2, pp.589-596, 2015.

C. Laurent, S. Burnouf, B. Ferry, V. L. Batalha, J. E. Coelho et al., A2A adenosine receptor deletion is protective in a mouse model of Tauopathy, Mol. Psychiatry, vol.21, issue.1, p.149, 2016.

C. Laurent, G. Dorothée, S. Hunot, E. Martin, Y. Monnet et al., Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy, Brain, vol.140, issue.1, pp.184-200, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01833350

A. Leboucher, C. Laurent, F. J. Fernandez-gomez, S. Burnouf, L. Troquier et al., Detrimental effects of diet-induced obesity on ? pathology are independent of insulin resistance in ? transgenic mice, Diabetes, vol.62, issue.5, pp.1681-1688, 2013.

E. Marciniak, A. Leboucher, E. Caron, T. Ahmed, A. Tailleux et al., Neurobiology of Disease, vol.125, pp.14-22, 2019.

E. Gerhardt, P. Pagesy, M. Vileno, C. Bournonville, M. Hamdane et al., Tau deletion promotes brain insulin resistance, J. Exp. Med, vol.214, issue.8, pp.2257-2269, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01833342

C. L. Masters, G. Simms, N. A. Weinman, G. Multhaup, B. L. Mcdonald et al., Amyloid plaque core protein in Alzheimer disease and down syndrome, Proc. Natl. Acad. Sci. U. S. A, vol.82, issue.12, pp.4245-4249, 1985.

A. M. Moloney, R. J. Griffin, S. Timmons, R. O'connor, R. Ravid et al., Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling, Neurobiol. Aging, vol.31, issue.2, pp.224-243, 2010.

R. J. Mullins, M. Mustapic, E. J. Goetzl, and D. Kapogiannis, Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease. Hum, Brain Mapp, vol.38, issue.4, pp.1933-1940, 2017.

P. T. Nelson, I. Alafuzoff, E. H. Bigio, C. Bouras, H. Braak et al., Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature, J. Neuropathol. Exp. Neurol, vol.71, issue.5, pp.362-381, 2012.

S. Obici, B. B. Zhang, G. Karkanias, and L. Rossetti, Hypothalamic insulin signaling is required for inhibition of glucose production, Nat. Med, vol.8, issue.12, pp.1376-1382, 2002.

G. Pandini, V. Pace, A. Copani, S. Squatrito, D. Milardi et al., Insulin has multiple antiamyloidogenic effects on human neuronal cells, Endocrinology, vol.154, issue.1, pp.375-387, 2013.

P. J. Randle, P. B. Garland, C. N. Hales, and E. A. Newsholme, The glucose fattyacid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet, vol.1, issue.7285, pp.785-789, 1963.

P. Rodriguez-rodriguez, A. Sandebring-matton, P. Merino-serrais, C. Parrado-fernandez, A. Rabano et al., Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons, Brain, vol.140, issue.12, pp.3269-3285, 2017.

K. Schindowski, A. Bretteville, K. Leroy, S. Bégard, J. P. Brion et al., Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits, Am. J. Pathol, vol.169, issue.2, pp.599-616, 2006.

N. Sergeant, A. Bretteville, M. Hamdane, M. L. Caillet-boudin, P. Grognet et al., Biochemistry of Tau in Alzheimer's disease and related neurological disorders, Expert Rev. Proteomics, vol.5, issue.2, pp.207-224, 2008.

G. W. Sharp, Mechanisms of inhibition of insulin release, Am. J. Phys, vol.271, issue.6, pp.1781-1799, 1996.

M. Stanley, S. L. Macauley, and D. M. Holtzman, Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?, J. Exp. Med, vol.213, issue.8, pp.1375-1385, 2016.

K. E. Steiner, R. W. Stevenson, D. R. Green, and A. D. Cherrington, Mechanism of epinephrine's glycogenolytic effect in isolated canine hepatocytes, Metabolism, vol.34, issue.11, pp.1020-1023, 1985.

K. Stevanovic, A. Yunus, A. Joly-amado, M. Gordon, D. Morgan et al., Disruption of normal circadian clock function in a mouse model of tauopathy, Exp. Neurol, vol.294, pp.58-67, 2017.

K. Talbot, H. Y. Wang, H. Kazi, L. Y. Han, K. P. Bakshi et al., Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline, J. Clin. Invest, vol.122, issue.4, pp.1316-1338, 2012.

P. Trayhurn, J. S. Duncan, and D. V. Rayner, Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system, Biochem J, vol.311, issue.3, pp.729-733, 1995.

L. Troquier, R. Caillierez, S. Burnouf, F. J. Fernandez-gomez, M. E. Grosjean et al., Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach, Curr. Alzheimer Res, vol.9, issue.4, pp.397-405, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00664452

L. P. Van-der-heide, A. Kamal, A. Artola, W. H. Gispen, and G. M. Ramakers, Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyld-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner, J. Neurochem, vol.94, issue.4, pp.1158-1166, 2005.

A. Van-der-jeugd, B. Vermaercke, M. Derisbourg, A. C. Lo, M. Hamdane et al., Progressive age-related cognitive decline in tau mice, J. Alzheimers Dis, vol.37, issue.4, pp.777-788, 2013.

M. Vidal, R. Morris, F. Grosveld, and E. Spanopoulou, Tissue-specific control elements of the Thy-1 gene, EMBO J, vol.9, issue.3, pp.833-840, 1990.

N. Wijesekara, D. Konrad, M. Eweida, C. Jefferies, N. Liadis et al., Muscle-specific Pten deletion protects against insulin resistance and diabetes, Mol. Cell. Biol, vol.25, issue.3, pp.1135-1145, 2005.

N. Wijesekara, R. A. Gonçalves, R. Ahrens, F. G. De-felice, and P. E. Fraser, Tau ablation in mice leads to pancreatic ? cell dysfunction and glucose intolerance, FASEB J, vol.32, issue.6, pp.3166-3173, 2018.

S. C. Woods, E. C. Lotter, L. D. Mckay, and D. Porte, Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons, Nature, vol.282, pp.503-505, 1979.

M. Yarchoan, J. B. Toledo, E. B. Lee, Z. Arvanitakis, H. Kazi et al., Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies, Acta Neuropathol, vol.128, issue.5, pp.679-689, 2014.

L. Zhao, B. Teter, T. Morihara, G. P. Lim, S. S. Ambegaokar et al., Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention, J. Neurosci, vol.24, issue.49, pp.11120-11126, 2004.

N. Zhao, C. C. Liu, A. J. Van-ingelgom, Y. A. Martens, C. Linares et al., Apolipoprotein E4 Impairs neuronal insulin signaling by trapping insulin receptor in the endosomes, Neuron, vol.96, issue.1, pp.115-129, 2017.